This is small -- but worthy of its own post, I believe. Two national columnists, this week, ran these headlines, about the proposed Sch-Merck transaction (the second refers also to the J&J Remicade/Simponi potential for reversion of non-US distribution rights) -- do click the embedded links, in each, to read the whole articles. They are very worthy reads:
. . . ."Schering and Merck: A Match Made in Purgatory"
-- Brian Orelli, The Motley Fool. . . .
. . . ."Who is the Most Desperate in This Bizarre Love Triangle?"
-- Jim Edwards, BNET Pharma. . . .
3 comments:
now that goli is getting the nod by the FDA, i would bet we hear of J&J's interest in the merger and their rights for the compound.
http://finance.yahoo.com/news/FDA-clears-potential-apf-15029849.html?.v=5
Thanks once again for the pickup!
Jim Edwards
cheap wow gold in obaoma.com
Post a Comment